Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
about
Group B Streptococcus vaccine: state of the artGram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary TractProgress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Interaction of neonatal phagocytes with group B streptococcus: recognition and response.Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytesPersistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines.Vaccination against group B streptococcus.Group B streptococcal infections in elderly adults.Toll-like receptor-dependent discrimination of streptococci.Molecular Characteristics of Group B Streptococci Isolated from Adults with Invasive Infections in Japan.Immune Responses to Invasive Group B Streptococcal Disease in Adults.An update on vaccination against group B streptococcus.Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease.Workshop on immunizations in older adults: identifying future research agendas.Invasive Group B streptococcus: multiloculated perinephric abscesses treated with percutaneous drainage.
P2860
Q26796438-2C72E8C6-F189-4E99-B23F-D884AAD1ADC6Q28829569-351D8226-548F-44C9-9964-DD92620A2660Q34112608-039939FD-7F20-40C9-8A50-186448BE4828Q34681095-8979FCA7-2B43-4E05-8BFA-F88C626C8492Q35634692-EB6B1859-55B6-4F13-B4EF-27A831C90566Q36083360-9D34B98E-9370-4686-89E6-F830922AB66FQ36124960-CA1B0B9D-A9A2-44A4-B67F-084A3E22B5ABQ36233889-370149B4-BAEF-4BA9-8A75-A40C639D1961Q36632391-5C7BD23E-E275-46A0-88F4-FA43731596F8Q37363399-DCC909EA-528B-4897-A698-51277328105EQ37382005-429615B9-0263-44F9-B08C-34C41B851F02Q37878487-BF2FA86E-72C8-4D9D-9E8F-0C3A5B6CF20CQ38844623-40CC1443-29FE-4D96-ADF2-9E36FEF7C4C1Q51774517-EB6F673A-E58F-436C-B919-110906833EEAQ52568269-F97B28D8-E803-4844-B3D6-3C2D7CA5A088
P2860
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
@en
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
@nl
type
label
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
@en
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
@nl
prefLabel
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
@en
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
@nl
P2093
P356
P1476
Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old.
@en
P2093
Carol J Baker
Debra L Palazzi
Marcia A Rench
Morven S Edwards
P304
P356
10.1086/422010
P407
P577
2004-06-30T00:00:00Z